TYME Presents New Preclinical Data Supporting SM-88 Mechanism of Action at AACR 2020

TYME has initiated comprehensive in vitro and in vivo experimental studies that are designed to elucidate the mechanism of action and further characterize the anti-cancer effects of SM-88 as a standalone investigational compound.